Rockwell Medical (RMTI) Competitors

$0.80 +0.02 (+2.18%)

Closing price 05/19/2026 04:00 PM Eastern

Extended Trading

$0.83 +0.03 (+3.58%)

As of 06:25 AM Eastern

RMTI vs. ARAY, ISRG, ABT, SYK, and MDT

Should you buy Rockwell Medical stock or one of its competitors? MarketBeat compares Rockwell Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Rockwell Medical include Accuray (ARAY), Intuitive Surgical (ISRG), Abbott Laboratories (ABT), Stryker (SYK), and Medtronic (MDT). These companies are all part of the "health care equipment" industry.

How does Rockwell Medical compare to Accuray?

Rockwell Medical (NASDAQ:RMTI) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 64.1% of Accuray shares are held by institutional investors. 1.9% of Rockwell Medical shares are held by company insiders. Comparatively, 4.4% of Accuray shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Rockwell Medical has a net margin of -7.98% compared to Accuray's net margin of -10.76%. Rockwell Medical's return on equity of -15.41% beat Accuray's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.98%	-15.41%	-9.62%
Accuray	-10.76%	-79.43%	-10.38%

Accuray has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Accuray, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.45	-$5.31M	-$0.15	N/A
Accuray	$458.51M	0.07	-$1.59M	-$0.37	N/A

In the previous week, Accuray had 1 more articles in the media than Rockwell Medical. MarketBeat recorded 3 mentions for Accuray and 2 mentions for Rockwell Medical. Rockwell Medical's average media sentiment score of 0.50 beat Accuray's score of -0.16 indicating that Rockwell Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rockwell Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Accuray	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Rockwell Medical has a beta of 1.65, meaning that its share price is 65% more volatile than the broader market. Comparatively, Accuray has a beta of 1.43, meaning that its share price is 43% more volatile than the broader market.

Rockwell Medical currently has a consensus price target of $2.00, suggesting a potential upside of 150.50%. Accuray has a consensus price target of $2.00, suggesting a potential upside of 599.79%. Given Accuray's higher probable upside, analysts clearly believe Accuray is more favorable than Rockwell Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Accuray	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Summary

Rockwell Medical beats Accuray on 9 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Intuitive Surgical?

Intuitive Surgical (NASDAQ:ISRG) and Rockwell Medical (NASDAQ:RMTI) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability, media sentiment and valuation.

Intuitive Surgical has a net margin of 28.15% compared to Rockwell Medical's net margin of -7.98%. Intuitive Surgical's return on equity of 15.98% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intuitive Surgical	28.15%	15.98%	14.07%
Rockwell Medical	-7.98%	-15.41%	-9.62%

In the previous week, Intuitive Surgical had 49 more articles in the media than Rockwell Medical. MarketBeat recorded 51 mentions for Intuitive Surgical and 2 mentions for Rockwell Medical. Intuitive Surgical's average media sentiment score of 1.27 beat Rockwell Medical's score of 0.50 indicating that Intuitive Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intuitive Surgical	41 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Rockwell Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Intuitive Surgical has a beta of 1.51, indicating that its share price is 51% more volatile than the broader market. Comparatively, Rockwell Medical has a beta of 1.65, indicating that its share price is 65% more volatile than the broader market.

Intuitive Surgical has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intuitive Surgical	$10.06B	15.54	$2.86B	$8.25	53.52
Rockwell Medical	$69.26M	0.45	-$5.31M	-$0.15	N/A

Intuitive Surgical currently has a consensus target price of $579.33, indicating a potential upside of 31.20%. Rockwell Medical has a consensus target price of $2.00, indicating a potential upside of 150.50%. Given Rockwell Medical's higher probable upside, analysts clearly believe Rockwell Medical is more favorable than Intuitive Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intuitive Surgical	1 Sell rating(s)	7 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.67
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 0.6% of Intuitive Surgical shares are owned by insiders. Comparatively, 1.9% of Rockwell Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Intuitive Surgical beats Rockwell Medical on 13 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Abbott Laboratories?

Abbott Laboratories (NYSE:ABT) and Rockwell Medical (NASDAQ:RMTI) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

Abbott Laboratories has a beta of 0.65, meaning that its stock price is 35% less volatile than the broader market. Comparatively, Rockwell Medical has a beta of 1.65, meaning that its stock price is 65% more volatile than the broader market.

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by insiders. Comparatively, 1.9% of Rockwell Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Abbott Laboratories has a net margin of 13.90% compared to Rockwell Medical's net margin of -7.98%. Abbott Laboratories' return on equity of 17.62% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	13.90%	17.62%	10.01%
Rockwell Medical	-7.98%	-15.41%	-9.62%

Abbott Laboratories currently has a consensus target price of $119.43, indicating a potential upside of 34.48%. Rockwell Medical has a consensus target price of $2.00, indicating a potential upside of 150.50%. Given Rockwell Medical's higher possible upside, analysts plainly believe Rockwell Medical is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	0 Sell rating(s)	5 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.88
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Abbott Laboratories had 46 more articles in the media than Rockwell Medical. MarketBeat recorded 48 mentions for Abbott Laboratories and 2 mentions for Rockwell Medical. Abbott Laboratories' average media sentiment score of 1.16 beat Rockwell Medical's score of 0.50 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	37 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Rockwell Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Abbott Laboratories has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	3.49	$6.52B	$3.57	24.88
Rockwell Medical	$69.26M	0.45	-$5.31M	-$0.15	N/A

Summary

Abbott Laboratories beats Rockwell Medical on 14 of the 17 factors compared between the two stocks.

How does Rockwell Medical compare to Stryker?

Rockwell Medical (NASDAQ:RMTI) and Stryker (NYSE:SYK) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment.

Rockwell Medical has a beta of 1.65, indicating that its share price is 65% more volatile than the broader market. Comparatively, Stryker has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market.

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 77.1% of Stryker shares are held by institutional investors. 1.9% of Rockwell Medical shares are held by insiders. Comparatively, 4.6% of Stryker shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Stryker had 18 more articles in the media than Rockwell Medical. MarketBeat recorded 20 mentions for Stryker and 2 mentions for Rockwell Medical. Stryker's average media sentiment score of 0.53 beat Rockwell Medical's score of 0.50 indicating that Stryker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rockwell Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Stryker	12 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Stryker has a net margin of 13.20% compared to Rockwell Medical's net margin of -7.98%. Stryker's return on equity of 23.42% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.98%	-15.41%	-9.62%
Stryker	13.20%	23.42%	11.04%

Stryker has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.45	-$5.31M	-$0.15	N/A
Stryker	$25.27B	4.82	$3.25B	$8.64	36.78

Rockwell Medical presently has a consensus target price of $2.00, indicating a potential upside of 150.50%. Stryker has a consensus target price of $395.48, indicating a potential upside of 24.44%. Given Rockwell Medical's higher possible upside, equities analysts clearly believe Rockwell Medical is more favorable than Stryker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Stryker	0 Sell rating(s)	6 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.73

Summary

Stryker beats Rockwell Medical on 14 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Medtronic?

Rockwell Medical (NASDAQ:RMTI) and Medtronic (NYSE:MDT) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

In the previous week, Medtronic had 30 more articles in the media than Rockwell Medical. MarketBeat recorded 32 mentions for Medtronic and 2 mentions for Rockwell Medical. Medtronic's average media sentiment score of 0.97 beat Rockwell Medical's score of 0.50 indicating that Medtronic is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rockwell Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Medtronic	23 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Medtronic has a net margin of 13.00% compared to Rockwell Medical's net margin of -7.98%. Medtronic's return on equity of 14.82% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.98%	-15.41%	-9.62%
Medtronic	13.00%	14.82%	7.88%

Rockwell Medical presently has a consensus target price of $2.00, suggesting a potential upside of 150.50%. Medtronic has a consensus target price of $107.80, suggesting a potential upside of 37.31%. Given Rockwell Medical's higher probable upside, research analysts plainly believe Rockwell Medical is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Medtronic	0 Sell rating(s)	11 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.58

Medtronic has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.45	-$5.31M	-$0.15	N/A
Medtronic	$33.54B	3.01	$4.66B	$3.59	21.87

Rockwell Medical has a beta of 1.65, suggesting that its stock price is 65% more volatile than the broader market. Comparatively, Medtronic has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market.

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 82.1% of Medtronic shares are held by institutional investors. 1.9% of Rockwell Medical shares are held by company insiders. Comparatively, 0.3% of Medtronic shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Medtronic beats Rockwell Medical on 13 of the 16 factors compared between the two stocks.

Get Rockwell Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RMTI vs. The Competition

Export

Metric	Rockwell Medical	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$30.84M	$8.31B	$6.25B	$12.23B
Dividend Yield	N/A	2.54%	2.80%	5.32%
P/E Ratio	-5.32	15.99	20.78	25.05
Price / Sales	0.45	7.42	523.93	70.99
Price / Cash	N/A	16.91	43.09	54.25
Price / Book	0.88	3.93	9.75	6.83
Net Income	-$5.31M	$224.05M	$3.55B	$335.69M
7 Day Performance	-0.34%	-1.95%	-2.11%	-2.15%
1 Month Performance	-14.95%	-4.26%	-4.15%	-2.47%
1 Year Performance	-25.38%	-1.03%	28.29%	27.13%

Rockwell Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RMTI Rockwell Medical	3.4167 of 5 stars	$0.80 +2.2%	$2.00 +150.5%	-23.2%	$30.84M	$69.26M	N/A	300
ARAY Accuray	2.4915 of 5 stars	$0.28 -5.7%	$2.00 +624.6%	-82.4%	$32.95M	$428.57M	N/A	1,040
ISRG Intuitive Surgical	4.2906 of 5 stars	$445.07 +1.2%	$579.33 +30.2%	-21.4%	$156.81B	$10.06B	53.67	17,021	Positive News Analyst Forecast
ABT Abbott Laboratories	4.9627 of 5 stars	$88.59 +0.8%	$119.43 +34.8%	-34.5%	$154.09B	$45.13B	24.78	115,000	Positive News
SYK Stryker	4.9594 of 5 stars	$314.46 +0.4%	$395.48 +25.8%	-19.5%	$120.55B	$25.12B	36.40	56,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RMTI) was last updated on 5/20/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rockwell Medical (RMTI) Competitors

RMTI vs. ARAY, ISRG, ABT, SYK, and MDT

How does Rockwell Medical compare to Accuray?

Summary

How does Rockwell Medical compare to Intuitive Surgical?

Summary

How does Rockwell Medical compare to Abbott Laboratories?

Summary

How does Rockwell Medical compare to Stryker?

Summary

How does Rockwell Medical compare to Medtronic?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RMTI vs. The Competition

Rockwell Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rockwell Medical (RMTI) Competitors

RMTI vs. ARAY, ISRG, ABT, SYK, and MDT

How does Rockwell Medical compare to Accuray?

Do institutionals and insiders hold more shares of RMTI or ARAY?

Is RMTI or ARAY more profitable?

Which has preferable valuation and earnings, RMTI or ARAY?

Does the media favor RMTI or ARAY?

Which has more risk & volatility, RMTI or ARAY?

Do analysts recommend RMTI or ARAY?

Summary

How does Rockwell Medical compare to Intuitive Surgical?

Is ISRG or RMTI more profitable?

Does the media refer more to ISRG or RMTI?

Which has more risk & volatility, ISRG or RMTI?

Which has higher earnings and valuation, ISRG or RMTI?

Do analysts rate ISRG or RMTI?

Do insiders & institutionals believe in ISRG or RMTI?

Summary

How does Rockwell Medical compare to Abbott Laboratories?

Which has more volatility & risk, ABT or RMTI?

Do institutionals and insiders have more ownership in ABT or RMTI?

Is ABT or RMTI more profitable?

Do analysts rate ABT or RMTI?

Does the media refer more to ABT or RMTI?

Which has stronger valuation and earnings, ABT or RMTI?

Summary

How does Rockwell Medical compare to Stryker?

Which has more risk and volatility, RMTI or SYK?

Do institutionals and insiders believe in RMTI or SYK?

Does the media favor RMTI or SYK?

Is RMTI or SYK more profitable?

Which has higher valuation and earnings, RMTI or SYK?

Do analysts prefer RMTI or SYK?

Summary

How does Rockwell Medical compare to Medtronic?

Does the media prefer RMTI or MDT?

Is RMTI or MDT more profitable?

Do analysts rate RMTI or MDT?

Which has higher earnings and valuation, RMTI or MDT?

Which has more risk & volatility, RMTI or MDT?

Do insiders & institutionals hold more shares of RMTI or MDT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RMTI vs. The Competition

Rockwell Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools